149 related articles for article (PubMed ID: 10455888)
1. Inhibition of gastric cancer by camptothecin involves apoptosis and multiple cellular pathways.
Litvak DA; Papaconstantinou HT; Hwang KO; Kim M; Evers BM; Townsend CM
Surgery; 1999 Aug; 126(2):223-30. PubMed ID: 10455888
[TBL] [Abstract][Full Text] [Related]
2. Targeting molecular pathways with camptothecin as novel therapy for gastric cancer.
Litvak DA; Papaconstantinou HT; Evers BM; Townsend CM
J Gastrointest Surg; 1999; 3(6):618-24. PubMed ID: 10554369
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in human gastric cancer by sodium butyrate.
Litvak DA; Hwang KO; Evers BM; Townsend CM
Anticancer Res; 2000; 20(2A):779-84. PubMed ID: 10810354
[TBL] [Abstract][Full Text] [Related]
5. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z
Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167
[TBL] [Abstract][Full Text] [Related]
6. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
7. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
8. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1.
Litvak DA; Evers BM; Hwang KO; Hellmich MR; Ko TC; Townsend CM
Surgery; 1998 Aug; 124(2):161-9; discussion 169-70. PubMed ID: 9706134
[TBL] [Abstract][Full Text] [Related]
9. Concomitant exposure of ovarian cancer cells to docetaxel, CPT-11 or SN-38 and adenovirus-mediated p53 gene therapy.
Miettinen S; Ylikomi T
Anticancer Drugs; 2009 Aug; 20(7):589-600. PubMed ID: 19491654
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I inhibitor (camptothecin)-induced apoptosis in human gastric cancer cells and the role of wild-type p53 in the enhancement of its cytotoxicity.
Zhang ZW; Patchett SE; Farthing MJ
Anticancer Drugs; 2000 Oct; 11(9):757-64. PubMed ID: 11129739
[TBL] [Abstract][Full Text] [Related]
11. p21Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line.
Zhang Y; Fujita N; Tsuruo T
Int J Cancer; 1999 Dec; 83(6):790-7. PubMed ID: 10597196
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.
Wuerzberger SM; Pink JJ; Planchon SM; Byers KL; Bornmann WG; Boothman DA
Cancer Res; 1998 May; 58(9):1876-85. PubMed ID: 9581828
[TBL] [Abstract][Full Text] [Related]
13. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways.
Zeng CW; Zhang XJ; Lin KY; Ye H; Feng SY; Zhang H; Chen YQ
Mol Pharmacol; 2012 Apr; 81(4):578-86. PubMed ID: 22252650
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
17. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent apoptosis in melanoma cells after treatment with camptothecin.
Li G; Bush JA; Ho VC
J Invest Dermatol; 2000 Mar; 114(3):514-9. PubMed ID: 10692111
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.
Weller M; Winter S; Schmidt C; Esser P; Fontana A; Dichgans J; Groscurth P
Int J Cancer; 1997 Nov; 73(5):707-14. PubMed ID: 9398050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]